Virginie W.
- Country
- France
- Department
- Pneumonology
Research Overview
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
- A Phase 3 Randomized Open-Label Study Comparing Sigvotatug Vedotin and Docetaxel in Adults with Previously Treated Non-Small Cell Lung Cancer
- Phase III Randomized Study of Lurbinectedin Alone or with Irinotecan Versus Topotecan or Irinotecan in Relapsed Small Cell Lung Cancer Patients
Data & Insights
Has run more than one trial at 155 of 367 partner sites.
Specializations
Non-Small Cell Lung Cancer
The investigator specializes in advanced therapeutic approaches for non-small cell lung cancer (NSCLC), with particular emphasis on stage III unresectable cases and metastatic disease. Their research encompasses innovative treatment combinations including immunotherapy and targeted therapies.
- Advanced and Metastatic NSCLC
- Stage III Unresectable Disease
- Immunotherapy Combinations
Small Cell Lung Cancer
The investigator conducts research in small cell lung cancer (SCLC) treatment, focusing on novel therapeutic approaches for patients who have experienced disease progression after initial treatment. Their work includes evaluation of innovative drug combinations and single-agent therapies.
- Relapsed SCLC
- Second-line Treatment Options
- Novel Therapeutic Combinations
Precision Medicine Approaches
The investigator explores personalized treatment strategies in lung cancer, including research on HLA-A2 positive phenotypes and tumors with specific genomic characteristics. Their work includes studies of therapeutic vaccines and targeted antibody treatments.
- Biomarker-Driven Therapies
- Cancer Vaccines
- Maintenance Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.